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Submucosal glands line the cartilaginous airways and produce most of the antimicrobial mucus
that keeps the airways sterile. The glands are defective in cystic fibrosis (CF), but how this
impacts airway health remains uncertain. Although most CF mouse strains exhibit mild air-
way defects, those with the C57Bl/6 genetic background have increased airway pathology and
susceptibility to Pseudomonas. Thus, they offer the possibility of studying whether, and if so
how, abnormal submucosal gland function contributes to CF airway disease. We used optical
methods to study fluid secretion by individual glands in tracheas from normal, wild-type (WT)
mice and from cystic fibrosis transmembrane conductance regulator (CFTR) knockout mice
(Cftrm1UNC/Cftrm1UNC; CF mice). Glands from WT mice qualitatively resembled those in humans
by responding to carbachol and vasoactive intestinal peptide (VIP), although the relative rates
of VIP- and forskolin-stimulated secretion were much lower in mice than in large mammals. The
pharmacology of mouse gland secretion was also similar to that in humans; adding bumetanide or
replacement of HCO3− by Hepes reduced the carbachol response by ∼50%, and this inhibition
increased to 80% when both manoeuvres were performed simultaneously. It is important to
note that glands from CFTR knockout mice responded to carbachol but did not secrete when
exposed to VIP or forskolin, as has been shown previously for glands from CF patients. Tracheal
glands from WT and CF mice both had robust secretory responses to electrical field stimulation
that were blocked by tetrodotoxin. It is interesting that local irritation of the mucosa using chili
pepper oil elicited secretion from WT glands but did not stimulate glands from CF mice. These
results clarify the mechanisms of murine submucosal gland secretion and reveal a novel defect
in local regulation of glands lacking CFTR which may also compromise airway defence in CF
patients.
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Cystic fibrosis (CF) is a common fatal disease caused
by mutations in the cystic fibrosis transmembrane
conductance regulator (CFTR) gene (cftr). Many epithelial
tissues are affected in CF; however, patients usually
succumb to respiratory failure that results from chronic
bacterial infection and inflammation in the airways
(Pilewski & Frizzell, 1999; Sheppard & Welsh, 1999).
While accumulation of abnormally thick mucus has long
been considered to be a hallmark of the lung disease of
CF, the events leading from CFTR mutations to airway
pathology remain poorly understood (Pilewski & Frizzell,
1999; Gibson et al. 2003).
There is evidence that airway submucosal glands, which
lie beneath the epithelium and are connected to the surface
by ducts, play an important role in the pathophysiology of
CF. They secrete mucus when stimulated by secretagogues
such as acetylcholine (ACh) or vasoactive intestinal
peptide (VIP). Dilatation of the submucosal gland ducts
with gland mucus is among the earliest pathological
changes observed in CF lungs (Oppenheimer & Esterly,
1975) and implicates the glands in pathogenesis before
the onset of chronic infections that irrevocably alter the
biology of the airways. Consistent with the role of CFTR
in submucosal gland function, glands from CF patients
have altered responses to secretagogues when compared
to normal glands (Jayaraman et al. 2001; Joo et al. 2002a,
2006; Verkman et al. 2003; Wine & Joo, 2004; Salinas
et al. 2005). Non-CF submucosal glands secrete fluid
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when stimulated with Ca2+-elevating agents (e.g. ACh or
carbachol) and/or cAMP agonists (e.g. VIP or forskolin)
whereas those from CF patients do not respond to VIP or
forskolin (Joo et al. 2002a) and produce a mucus during
stimulation with carbachol that is thicker (Jayaraman et al.
2001) and more acidic (Song et al. 2005).
Airway submucosal glands are complex structures that
normally produce mucus in response to a wide range
of different stimuli (Ballard & Inglis, 2004; Wine & Joo,
2004). Electrical stimulation of the superior laryngeal
nerves elicits tracheal mucus secretion, and this provided
early evidence for neuronal control of mucus secretion
(Johnson, 1935). Submucosal gland secretion is controlled
by parasympathetic and possibly sympathetic innervation
as well as by local release of stimulatory signals from
nociceptive sensory nerves comprising C- and Aδ-fibres
(Barnes, 2001; Tai & Baraniuk, 2002; Widdicombe, 2003;
Ballard & Inglis, 2004). Although the relative roles of
local and central regulatory pathways in CF has not been
investigated, airways from normal donors can remain
functional and uninfected for many years when trans-
planted into CF patients despite their lack of central
sympathetic and parasympathetic innervation. As central
regulation is not essential for airway host defence, the
clinical experience implicates abnormal local regulation
of gland function in CF.
Submucosal glands have been studied using human
biopsies, transplant samples or human volunteers, but
an animal model would be useful. CF mice offer many
potential advantages: a consistent supply of tissue for
experimentation; control over bacterial infection and
disease severity; and the possibility of crossing CF
mice with other transgenic and knockout mice to gain
new insights into roles of particular channels, trans-
porters and signalling pathways in gland function. With
these advantages in mind, we undertook a study of
tracheal submucosal glands in an inbred congenic CFTR
knockout mouse strain (C57BL/6J Cftrm1UNC/Cftrm1UNC
(CF mouse); for reviews see Stotland et al. 2000; Davidson
& Dorin, 2001). CF mice do not have gross lung disease
under normal conditions and their gland phenotype is
therefore a direct consequence of CFTR deficiency. It is
important to note that when CFTR−/− C57BL/6J mice
are challenged with Pseudomonas aeruginosa they are more
susceptible to lung infection than their CFTR-expressing
littermates (Gosselin et al. 1998; Tam et al. 1999; Sapru
et al. 1999; Schroeder et al. 2001) and develop spontaneous
and progressive lung disease of early onset (Kent et al.
1997; Durie et al. 2004), including abnormal mucociliary
clearance (Cowley et al. 1997; Durie et al. 2004). Their
airway phenotype includes postbronchiolar over-inflation
(Durie et al. 2004), an increase in goblet cells, and
decreased airway surface liquid in the nasal epithelium
(Tarran et al. 2001). For these reasons, and to exploit the
wealth of information available on rodent airway physio-
logy, we examined submucosal gland fluid secretion in
tracheas from wild-type (WT) and CF mice.
Our results show that glands from normal mice secrete
fluid when stimulated by the muscarinic agonist carbachol
or by the cAMP agonists VIP and forskolin, as has been
reported previously for glands in larger species including
humans. Carbachol-induced secretion was inhibited by the
calcium-activated chloride channel blocker niflumic acid
and was unaffected in CF mice, whereas the VIP–forskolin
pathway was insensitive to this inhibitor and was not
detectable in the CFTR knockout animals. Interestingly,
local stimulation of airway sensory nerves by luminal
application of an irritant (chili pepper oil) triggered
fluid secretion by WT but not CF mouse submucosal
glands, although glands from both WT and CF mice
were responsive to electrical field stimulation (EFS). These
results indicate that a local neuronal reflex controls airway
submucosal glands and is greatly diminished in CF, and
suggests that mouse airway submucosal glands provide a
useful model for studying the regulation of normal and CF
human glands.
Methods
Mice
Congenic C57BL/6J (B6) CFTR heterozygote and homo-
zygous B6 CFTR−/− (CF) and B6 CFTR+/+ (WT litter
mates) mice were kindly provided by Dr Christina Haston,
Department of Medicine, McGill University (Haston et al.
2002). The tails were clipped at 18 days of age and genomic
DNA was isolated for subsequent cftr genotyping using a
PCR assay reported previously (Kent et al. 1997). Due to the
risk of death from intestinal obstruction, all CF mice were
maintained on a liquid diet (Peptamen) from the age of
18 days (Kent et al. 1996). WT mice of the same strain from
Charles River Canada (Saint-Constant, Quebec, Canada)
or the Veterinary Service Center (Stanford, CA, USA) were
used to study the effects of ouabain, bumetanide, niflumic
acid and replacement of HCO3− by Hepes on secretion
by normal glands as well as the effect of electrical field
and chili pepper oil stimulation. For all other experiments
with CF mice, comparisons were made between the
CFTR−/− mice and their CFTR+/+ littermates. Mice
were housed in the animal facility at McGill University
or the Department of Laboratory Animal Care facility,
Department of Comparative Medicine at Stanford School
of Medicine. All procedures followed Canadian Institutes
of Health Research (CIHR) and National Institutes of
Health (NIH) rules and were approved by the faculty
Animal Care Committees at each institution.
Tracheal preparation
Mice (10–12 weeks old) were killed by exposure to
100% carbon dioxide and tracheas were immediately
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dissected and placed in ice-cold Krebs–Ringer bicarbonate
buffer containing (mm): NaCl 115, K2HPO4 2.4, KH2PO4
0.4, CaCl2 1.2, MgCl2 1.2, NaHCO3 25 and glucose
10; pH 7.4, equilibrated to 95% O2–5% CO2. To
minimize tissue exposure to endogenously generated
prostaglandins during tissue preparation and mounting,
1.0 μm indomethacin was present in the bath throughout
the experiment. The dissection was modified from the
methods of Joo et al. (2001b): the trachea was cut dorsally
along its length and placed in a custom-built chamber
mucosal-side up so that the serosal side was bathed in
∼60 μl Krebs-Ringer solution and the mucosal side was
exposed to air. The luminal surface was gently cleaned
with absorbent paper, dried with a stream of air, and
coated with ∼5 μl mineral oil (water saturated) between
the first and third cartilage rings. To avoid any possibility
of tissue damage that might trigger nociceptive responses,
the luminal surface was not cleaned with absorbent
paper during the experiments involving chili pepper oil.
Droplets of mucus formed under oil during secretion
by individual submucosal glands, as first described for
insect Malpighian tubules by Ramsay (1954) and modified
for trachea by Quinton (1979). The tissue was placed
in a temperature-controlled system (TC-102, Medical
Systems Corp., Greenvale, NY, USA), warmed to 37◦C at a
rate of ∼2◦C min−1, and continuously exposed to warm,
humidified 95% O2–5% CO2. Pharmacological agents
were added to the serosal side.
EFS
Responses to EFS were investigated by passing current
through platinum electrodes placed at the caudal and
frontal end of the isolated trachea. Pulses (20 V, 5 Hz,
10 ms) were applied for 1 min using a Grass SD9 stimulator
(Quincy, MA, USA), because those parameters yielded
maximal and reproducible secretion rates in preliminary
experiments.
Exposure to a chemical irritant
Airway responses to chemical irritants have been studied
using a wide range of insults including ammonia vapour
(Phipps & Richardson, 1976), cigarette smoke (Schultz
et al. 1991), capsaicin (Schultz et al. 1985), ozone (McBride
et al. 1991), nitrogen dioxide (Holroyd et al. 1997) and
diesel exhaust (Ichinose et al. 1998; Miyabara et al. 1998).
To measure secreted droplets, the tracheal preparation
must be coated with oil, which precludes the use of air-
or water-borne irritants. Therefore we used commercially
available hot chili pepper cooking oil as a source of
capsaicin and other chemical irritants (Melina’s, Pepper
Mill Imports, Carmel, CA, USA). After measuring basal
secretion rate, a small volume (0.5 μl) of chili pepper
oil was gently added to the 5 μl paraffin oil bathing the
mucosal surface.
Calculation of secreted volume
As with larger mammalian species, droplets of mucus
formed at gland openings (Fig. 1). Images were taken
at 30 s intervals using a digital camera (MiniVID,
LW Scientific, Lawrenceville, GA, USA) mounted on a
dissecting microscope and were stored for off-line analysis.
Stored images were analysed using ImageJ 1.32J (NIH).
Secretion volumes were calculated as previously described
using the formula: V = 4/3π r3, where r is the radius (Joo
et al. 2001b). To be included in the analysis, each droplet
had to meet the following criteria: (a) circular outline so
that a spherical shape could be assumed; (b) clear edges
to allow accurate measurement of the radius; and (c) no
fusion with neighbouring droplets. Viability was tested at
the end of each experiment by measuring the response
to carbachol and those glands that did not respond to
carbachol (< 5%) were excluded from the analysis.
The secretion rate was calculated by fitting the volume
versus time plots with straight lines using linear regression
and the slopes were taken as the secretion rates using at
least three points. Rates were expressed in nl min−1 except
when they were low and so would be clearer in pl min−1.
The r2 value for such linear fits was > 0.8.
Reagents
Stock solutions of carbachol, adrenaline (epinephrine)
and VIP were dissolved directly in Krebs–Ringer
solution. Indomethacin, atropine, tetrodotoxin, forskolin,
bumetanide, niflumic acid and CFTRinh172 stocks were
prepared in DMSO. The final DMSO concentration
Figure 1. Fluid secretion by mouse airway submucosal glands
Digital image of mucus droplets that form under paraffin oil following
stimulation of isolated mouse trachea with carbachol. Mouse glands
are smaller than those in humans but there are more per unit area in
this region of the trachea.
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did not exceed 0.1%, a concentration which did not
affect fluid secretion in response to carbachol during
control experiments (data not shown). The vehicle for
stock solutions was Krebs–Ringer solution. Reagents
were obtained from Sigma (St Louis, MO, USA) except
for CFTRinh172, which was obtained from Calbiochem
(Darmstadt, Germany).
Statistics
Data are presented as means ± s.e.m. and were analysed
using ANOVA, Student’s t test or F test as appropriate,
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Figure 2. Cumulative secreted volumes versus time from single
glands
Carbachol (1 μM) was added at time 0. Each curve indicates the fluid
secreted by one gland. A, wild-type mice (n = 7 glands from four
tracheas). B, CFTR−/− mice (n = 7 glands from three tracheas). Insets
show the calculated secretion rates.
with P < 0.05 considered significant. Linear regression
was performed using SigmaPlot 9 (Systat Software,
Point Richmond, CA, USA). Non-linear regressions were
performed using GraphPad Prism 4 (GraphPad Software
Inc., San Diego, CA, USA).
Results
Although most submucosal glands were quiescent
immediately after isolation, about one-third of the glands
began producing fluid spontaneously as they were warmed
from room temperature and became quiescent by the
time they reached 37◦C. The initial fluid volume at 37◦C
was subtracted from subsequent measurements when
calculating secretion rates.
Responses to cholinergic stimulation
Ach activates muscarinic receptors and is a potent stimulus
of fluid secretion by submucosal glands in humans and
other large mammals. To examine the possible role of
CFTR in cholinergically stimulated secretion we compared
responses when glands from CF mice and their WT
littermates were exposed to the muscarinic receptor
agonist carbachol. At each carbachol concentration, we
examined tracheas from at least two WT and CF mice
(n = 2–4) in order to have at least six glands with
secretion properties matching our inclusion criteria. Large
stimulations were observed using tracheas from four WT
(Fig. 2A) and three CF mice (Fig. 2B) exposed to 1 μm
carbachol at t = 0. Similar numbers of glands from WT and
CF mice responded to carbachol (WT, 15 ± 2 glands per
trachea from a total of 61 glands; CF, 16 ± 1.5 glands per
trachea from a total of 48 glands). Carbachol stimulation
of CFTR−/− glands suggests involvement of another type
of apical chloride channel besides CFTR. Experiments
were performed at several carbachol concentrations from
100 nm to 100 μm and the results were fitted to a
three-parameter logistic curve by non-linear regression
(Fig. 3). Seven glands from each group met the criteria
for quantifying secretion rate and were included in the
dose–response curve. The best-fit curves for stimulation of
glands from WT and CF animals did not differ significantly
(F test, P > 0.8). Thus, the EC50 for carbachol was not
altered in glands from CF mice (1.8 μm, 95% confidence
interval at 0.3–8 μm) when compared with those from
WT littermate controls (1.7 μm, 95% confidence inter-
val at 0.8–4 μm), and the maximum secretion rate (V max)
also did not differ significantly (1.66 ± 0.25 (n = 36) and
1.58 ± 0.16 nl min−1 (n = 55), respectively).
Most fluid secretion by submucosal glands from sheep
(Joo et al. 2001b), pigs (Inglis et al. 1997; Ballard et al.
1999, 2006; Trout et al. 2001; Joo et al. 2002b) and
humans (Joo et al. 2002a) is driven by net Cl− and
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HCO3− transport (Ballard & Inglis, 2004). Cl−-driven
fluid secretion involves basolateral entry of Cl−, K+
and Na+ via Na+–K+–2Cl− (NKCC1) cotransporters
and apical exit through anion channels, with energy
for the uphill chloride entry ultimately provided by the
Na+–K+-ATPase pump (reviewed by Verkman et al. 2003).
We tested this model in mouse submucosal glands by
measuring the effects of known inhibitors on carbachol
(50 nm)-induced fluid secretion. This concentration of
carbachol was used to stimulate a low rate of secretion
so that merging of neighbouring secreted droplets during
long experiments would be minimized, although we
recognize that the pattern of inhibition revealed by these
low concentrations may differ from that seen with much
higher concentrations, for a variety of reasons.
Figure 4A–D shows the net (cumulative) secretion by
individual glands and Fig. 4E summarizes the mean rate
under various conditions. All the transport inhibitors
caused plateaux in the cumulative volume versus time plots
as expected from the model for gland secretion. Adding
the Na+–K+-ATPase inhibitor ouabain (1 mm) to the
basolateral side reduced carbachol-stimulated secretion
from 60 ± 10 pl min−1 (n = 10 glands from five tracheas)
to 7.0 ± 4.0 pl min−1 within 35 min (n = 5 glands from
three tracheas, one-way ANOVA, P < 0.05; Fig. 4C and E).
Secretion rates measured between 15 and 35 min after the
addition of bumetanide (10 μm) were also significantly
lower than in control glands when stimulated by 50 nm
carbachol for 35 min (one-way ANOVA, P < 0.05, n = 5
glands from three tracheas; Fig. 4B and E). To examine the
possible role of Ca2+-activated Cl− channels in stimulation
by carbachol, we tested the effect of niflumic acid on
fluid secretion rate. Niflumic acid (10 μm) abolished
carbachol-induced fluid secretion within 20 min (n = 8
glands from four tracheas, one-way ANOVA, P < 0.05;
Fig. 4D and E).
To investigate the roles of Cl− and HCO3− in mouse sub-
mucosal gland secretion we examined carbachol-induced
responses after adding 40 μm bumetanide to block
Cl− transport by the NKCC1 cotransporters, and
after replacement of HCO3− by Hepes to eliminate
HCO3− transport, and after both of these treatments
in combination (Fig. 5). In the absence of inhibitors,
the concentration dependence of the carbachol responses
yielded an EC50 of 0.51 ± 0.03 μm and an average
V max of 1.84 ± 0.02 nl min−1 (n = 68 glands from five
tracheas). Although the EC50 was not affected significantly
by the presence of 40 μm bumetanide (0.62 ± 0.03 μm,
Student’s t test, P > 0.2), V max was reduced by 40% to
1.1 ± 0.03 nl min−1 (n = 44 glands from five tracheas,
Student’s t test, P < 0.05). When glands were stimulated
with carbachol in Hepes-buffered Krebs-Ringer solution
lacking HCO3− and gassed with O2, the EC50 was again
unaffected whereas secretion in response to carbachol
was inhibited by 55% and the V max was reduced to
0.8 ± 0.1 nl min−1 (n = 52 glands from five tracheas,
Student’s t test, P < 0.05). Finally, with simultaneous
addition of bumetanide and replacement of HCO3− by
Hepes, V max was reduced by 80% to 0.39 nl min−1 (n = 36
glands from four tracheas, Student’s t test, P < 0.01). We
conclude that chloride and bicarbonate both contribute
significantly to carbachol-induced secretion in mouse sub-
mucosal glands under these conditions.
Responses to VIP-, forskolin- and adrenaline-induced
stimulation
In humans, airway submucosal glands secrete in response
to VIP and forskolin whereas those from CF patients
do not (Joo et al. 2002a). We compared fluid secretion
by WT and CF mouse glands during stimulation by
VIP and forskolin, to see whether this CF phenotype
is also manifested in mice. In glands from WT mice,
VIP at 10 μm produced small responses with long and
variable latencies, possibly because of physical barriers and
abundant peptidases in the tissue. Increasing the serosal
VIP concentration to 100 μm caused significant mucus
secretion in half the WT mouse glands tested (21/42
glands from three tracheas); however, no secretion was
detected using glands from CFTR−/− littermates (0/62
glands from six tracheas). The criteria for quantification
were met by six WT (Fig. 6A) and 12 CF mice glands
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Figure 3. Mean concentration dependence of carbachol
stimulation in wild-type (WT) and CFTR−/− knockout mouse
glands
Data from WT ( ) and CFTR−/− (•) submucosal glands were fitted
with a three-parameter logistic curve using non-linear regression
(n = 6 glands for each point). The concentration giving half-maximal
stimulation (EC50) was 1.7 μM for WT mice and 1.8 μM for CFTR−/−
mice. Maximum secretion rates (Vmax) were also similar:
1.58 ± 0.16 nl min−1 (n = 55) and 1.66 ± 0.25 (n = 36), respectively.
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Figure 4. Effect of bumetanide, ouabain and niflumic acid on carbachol stimulated fluid secretion by
wild-type (WT) mouse submucosal glands
A, effect of 50 nM carbachol on submucosal glands (n = 11 glands from five tracheas). B, effect of 10 μM
bumetanide on fluid secretion (n = 5 glands from three tracheas). C, effect of 1 mM ouabain on fluid secretion
(n = 5 glands from two tracheas). D, effect of 10 μM niflumic acid on fluid secretion by mouse submucosal glands
(n = 8 glands from from tracheas). E, effect of bumetanide, ouabain and niflumic acid on carbachol-induced fluid
secretion rate (mean + S.E.M.). The secretion rate during the time interval 15–35 min after addition of blocker
was compared with that measured after 35–55 min stimulation with carbachol. ∗Significant differences (Student’s
t test, P < 0.05) between the control and experimental groups.
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(Fig. 6B). Elevating cAMP with 10 μm forskolin also
stimulated submucosal gland fluid secretion in tracheas
from WT mice (72/102 glands from seven tracheas;
Fig. 7A) but not in tracheas from their CF littermates
(0/36 glands from three tracheas; Fig. 7B) although the
CF mouse glands did respond vigorously to carbachol.
The rates induced by VIP and forskolin were similar
(40 ± 10 (n = 3 tracheas) and 30 ± 10 pl min−1, (n = 7
tracheas), respectively) and were insensitive to 10 μm
niflumic acid and the muscarinic receptor antagonist
atropine (10 μm) (data not shown). Thus VIP does
not stimulate epithelial Ca2+-activated Cl− channels or
indirectly stimulate muscarinic receptors in this complex
tissue. In some species such as cat, α-adrenergic receptors
stimulate copious submucosal gland secretion (Quinton,
1979; Joo et al. 2001a,b), whereas glands in other species
such as sheep, pigs and humans are not responsive
(Joo et al. 2001a,b) and β-adrenergic receptor activation
stimulates only modest secretion (Leikauf et al. 1984; Joo
et al. 2001b). However adrenaline, which should activate
both α and β-adrenergic receptors, did not stimulate
glands from WT mice when tested at concentrations up
to 1 mm (data not shown).
Gland responses to local (chili pepper oil) and to local
and central (EFS) stimuli
Chemical irritants stimulate fluid secretion in mammalian
airways in part through a local reflex that involves
anterograde transmitter release by sensory neurons
(Barnes, 2001; Widdicombe, 2003; De Swert & Joos,
2006), but it is not known whether this local reflex
is affected in CF. We used tracheas from WT and CF
mice to compare secretory responses to chili pepper
oil, which is a rich source of the lipophilic capsaicinoid
capsaicin (8-methyl-N-vanillyl-6-nonenamide) and
related molecules such as di-hydrocapsaicin and
nordihydrocapsaicin. Capsaicin depolarizes sensory
neurons (C-fibres in airways) and other cell types that
express the ionotropic vanilloid (VR1) receptor (Szallasi,
2001).
Adding chili pepper oil to the surface of WT mouse
trachea consistently increased the rate of gland secretion
from 1 ± 0.8 to 20 ± 4 pl min−1 (Student’s t test, P < 0.05,
n = 29 glands from eight tracheas). Chili pepper oil was
added 60 min after initiation of the experiment shown in
Fig. 8A and B. When tracheas were incubated for 60 min
with the CFTR inhibitor CFTRinh172 (nominally 100 μm;
Fig. 8C), fluid secretion in response to chili pepper oil was
blocked. In WT mouse tracheas, 32 of 78 glands (41%)
responded to chili pepper oil, but in seven tracheas pre-
incubated with CFTRinh172, 0/54 glands responded to
stimulation with chili pepper oil although they had robust
responses to carbachol (Fig. 8C).
To examine whether capsaicinoids act directly on the
glands or through a local reflex, chili pepper oil was applied
to WT tracheas that had been pretreated with tetrodotoxin
(TTX; 1 μm) for 60 min to block neuronal voltage-gated
sodium channels (Fig. 9). The secretory response to chili
pepper oil was abolished under these conditions (24 glands
in three tracheas) whereas responses to VIP (100 μm) and
carbachol (1 μm) were unaffected. These results suggest
that chemical stimulation by capsaicin is mediated by a
local nerve reflex whereas VIP and carbachol act directly
on gland receptors. The ability of intratracheal nerves to
stimulate vigorous mucus secretion in this preparation was
confirmed by using EFS. Mean secretion rate increased
from 1 ± 0.3 to 80 ± 20 pl min−1 after application of
voltage pulses as described in the Methods (Student’s t test,
P < 0.05, n = 12 glands from three WT tracheas; Fig. 10).
We conclude that local regulation by nociceptive stimuli
involves TTX-sensitive neurons. The stronger secretory
response to EFS may result, in part, from activation of
both local sensory afferent nerves and surviving central
parasympathetic preganglionic axons that release Ach and
perhaps other agonists onto the gland cells.
The role of CFTR in mediating chili pepper oil-induced
fluid secretion was assessed by studying its effect in tracheas
from CF mice. In marked contrast to submucosal glands
from normal mouse, those from CF mouse did not respond
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Figure 5. Effect of 40 μM bumetanide, replacement of
bicarbonate by Hepes, and both interventions simultaneously
on carbachol-induced secretion
Data were fitted to a three-parameter logistic curve using non-linear
regression. Control carbachol responses (•) yielded EC50 of
0.51 ± 0.03 μM and maximal secretion rate (Vmax) of
1.84 ± 0.02 nl min−1 (68 glands from five tracheas). Vmax was
decreased by 40% when glands were exposed to 40 μM bumetanide
( ), by 55% by replacement of bicarbonate-containing Krebs-Ringer
solution by Hepes-buffered solution lacking HCO3− and gassed with
O2 (), and by 80% with the combined treatment (). EC50 values
were not affected significantly by the treatments.
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to chili pepper oil stimulation, indicating a profound defect
in the local control of gland function (12 glands from
four tracheas; Fig. 11). Although CF mouse glands did not
respond to chili pepper oil, they still had robust secretion
during EFS. This result is consistent with retention of the
cholinergic response in CF mouse glands and confirms
that insensitivity to irritants was not caused by a loss of
viability (Fig. 11).
Discussion
The present findings suggest that the isolated mouse
trachea is useful for studying the physiological control
of normal and CF airway submucosal glands. Although
the absolute rate of cAMP-stimulated gland secretion in
mice was much lower than in humans or pigs, functional
properties of the glands were qualitatively similar. It is
interesting that the secretory response to local irritants
is lost in CF mice, a feature of the CF phenotype that has
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Figure 6. Effect of VIP on cumulative fluid
volumes and secretion rates
VIP (100 μM) was added to glands at time 0. A,
Wild-type (n = 6 glands from three tracheas) and B,
CFTR−/− (n = 12 glands from five tracheas) mice.
Carbachol (1 μM) was added to the glands from
CFTR−/− mice shown in B to confirm their viability. The
insets show the secretion rates.
not been reported previously. This has implications for
host defence in human disease because local regulatory
mechanisms may mediate responses to minor insults that
are normally innocuous in healthy airways but become
severe in CF. Whether these local mechanisms are activated
by the opportunistic pathogen Pseudomonas aeruginosa
remains to be established.
Advantages and disadvantages of the mouse
submucosal gland model
Although it is sometimes erroneously stated that mice
lack airway glands or have only one or two, we observed
duct openings for 15–20 airway glands in the upper
mouse trachea. Glands are more abundant in CFTR−/−
animals and extend further down the trachea than in
WT mice (Borthwick et al. 1999). The present results
indicate that the functional properties of mouse glands
that we tested are qualitatively similar to those in humans
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and other large mammals. As in other species, carbachol
caused robust secretion, with an EC50 of ∼1 μm and
V max of ∼1.6 nl min−1, although detailed comparisons
of EC50 and V max values are not possible because
concentration–response curves for carbachol have not
been reported for other animals. The secretion rates at
10 μm carbachol were 16 nl min1 in sheep (Joo et al. 2001)
and 12 nl min−1 in pigs (Joo et al. 2002), which are much
higher values and may reflect larger gland size.
Aspects of the model for submucosal gland secretion
were explored and found to parallel those in human glands.
The prevailing model for serous cell ion transport involves
Cl− uptake by basolateral NKCC1 cotransporters, which
is driven by the inward sodium gradient generated by
Na+–K+-ATPase pumps, and passive Cl− efflux through
apical CFTR or Ca2+-activated channels (Singh et al. 1997;
Lee et al. 1998; Devor et al. 1999; Inglis et al. 2002). Our
pharmacological results are consistent with this scheme in
that bumetanide, a blocker of the NKCC1 cotransporter,
and ouabain, a Na+–K+-ATPase inhibitor that would
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Figure 7. Effect of forskolin (10 μm) on
submucosal gland secretion
A, wild-type (n = 6 glands from seven tracheas) and B,
CFTR−/− (n = 7 glands from three tracheas) mice.
Carbachol (1 μM) was added to the CFTR−/− knockout
mouse glands as a positive control for viability. The
insets show the secretion rates.
diminish the favourable sodium gradient, both strongly
inhibited carbachol-induced fluid secretion. Bicarbonate
replacement also reduced carbachol responses by ∼50%,
suggesting that muscarinic secretion by mouse submucosal
glands is mediated by Cl− and HCO3− as reported for
glands from sheep (Joo et al. 2001a,b), pigs (Inglis et al.
1997; Ballard et al. 1999, 2006; Trout et al. 2001; Joo et al.
2002) and humans (Joo et al. 2001a,b, 2002).
Carbachol responses were similar in glands from
WT and CF mice indicating the involvement of other,
non-CFTR Cl− channels. Ca2+-activated Cl− channels are
the most likely candidates because low-level carbachol
stimulation was abolished by niflumic acid, which
does not inhibit voltage-dependent chloride channels
(Suzuki et al. 2006). This conclusion is supported by
the patch-clamp studies of Griffin et al. (1996), who
found that Ca2+-activated Cl− channels in cultured
ovine submucosal gland cells are stimulated by 20 μm
methacholine and blocked by 10 μm niflumic acid. The
carbachol-stimulated Cl− channels apparently have little
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role in cAMP-stimulated secretion because responses to
VIP and forskolin were insensitive to niflumic acid and
atropine, and were completely absent in glands from
CF mice. Although the second messenger pathways and
channels that mediate VIP and muscarinic responses in
mouse submucosal glands appear distinct in WT mice,
we cannot rigorously exclude the possibilty of muscarinic
activation of CFTR in WT mouse glands because it
would probably be obscured by the much larger carbachol
response and would therefore not differ significantly from
the response in CF mouse glands.
About half the glands from WT mice responded to
VIP and forskolin, although it was necessary to use very
high VIP concentrations despite the high affinity of VPAC
receptors for VIP (EC50 in the low nanomolar range).
The cAMP-dependent secretion rates were only ∼2% of
those produced by stimulation with carbachol, in marked
contrast to pig and human glands where forskolin- and
VIP-induced secretion is about ∼25% that of maximum
carbachol-induced rates (Joo et al. 2001a,b, 2002a,b; Trout
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Figure 8. Effect of chili pepper oil (capsaicinoids) on fluid secretion by submucosal glands from wild-type
mice
A, secreted volume (32 glands from eight tracheas) before and after addition of chili pepper oil. Note the break
in the ordinate. B, secretion rates calculated under control conditions and after exposure to chili pepper oil (n = 8
tracheas). C, chili pepper oil response measured in the presence of CFTRinh172 (nominally 100 μM; n = 53 glands
from seven tracheas). Carbachol (1 μM) was added to the CFTRinh172-treated glands as a positive control for
viability.
et al. 2001). Because small responses were also produced
by forskolin, they probably reflect a reduced capacity
for cAMP-mediated secretion in mouse glands rather
than lower receptor expression. In summary, submucosal
glands from normal mice have low rates of VIP- and
forskolin-induced secretion, but as in human glands this
response requires CFTR (Joo et al. 2001a,b, 2002a,b).
CFTR-dependent response of the glands
to mucosal irritants
Mucus secretion is stimulated by many chemical irritants
and has been studied using exposure to ammonia vapour in
cat tracheas (Phipps & Richardson, 1976), cigarette smoke
and capsaicin in dog (Schultz et al. 1985, 1991) and ozone
in ferret (McBride et al. 1991). Nociception is mediated
by C- and Aδ-fibres that are situated in the airway wall
and have terminals within the surface epithelium (e.g.
Hunter & Undem, 1999; reviewed by Widdicombe, 2003).
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Figure 9. Effect of tetrodotoxin (TTX) on
responses to chili pepper oil, VIP (100 μM) and
carbachol (1 μM)
The first time point shown is at 40 min; however, TTX
(1 μM) was added at t = 0, then glands were
sequentially exposed to chili pepper oil, VIP and
carbachol (n = 24 glands from three tracheas).
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Figure 10. Effect of electrical field stimulation (EFS) on fluid
secretion by submucosal glands from wild-type mice
A, cumulative fluid secretion by individual glands before and after EFS
(duration indicated by hatched vertical bar). B, mean secretion rates
calculated immediately before and after EFS. ∗Significant difference
between the control and experimental groups (12 glands from two
tracheas).
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Figure 11. Effect of chili pepper oil and electrical field
stimulation (EFS) on fluid secretion by submucosal glands from
CFTR−/− knockout mice
Note insensitivity to capsaicinoids but strong regulation by EFS to
mimic central nervous system stimulation (12 glands from four
tracheas). Most glands were non-secreting until stimulated by EFS
(duration indicated by hatched vertical bar), despite the presence of
chili pepper oil.
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Stimulation of C- and Aδ-fibres causes local anterograde
release of the tachykinin substance P (SP), neurokinin
A (NKA) and calcitonin gene-related peptide (CGRP)
(McDonald, 1987; Ne´meth et al. 2003; Widdicombe, 2003)
which, like Ach and VIP, trigger secretion when applied
directly to the submucosal gland (Webber et al. 1991; Trout
et al. 2001; Barnes, 2001; Phillips et al. 2003; Ballard &
Inglis, 2004). In rodents, there is strong evidence that
airway sensory neurons stimulate mucus secretion by
triggering a local reflex and antidromic release of SP, NKA
and CGRP in addition to a reflex mediated by the central
nervous system (McDonald, 1987; Solway & Leff, 1991;
Barnes, 2001).
It has been suggested that SP-induced fluid secretion
may involve CFTR and be defective in CF (Trout et al.
2001); however, the role of local reflexes and SP in CF
mouse gland secretion has not previously been examined.
We found that exposing the tracheal epithelium to chili
pepper oil, which is rich in capsaicinoids that should
stimulate transient receptor channels, triggered mucus
secretion by submucosal glands from WT but not CF
mice. Because all central innervation of the trachea
was severed during isolation, this regulation is pre-
sumably triggered locally by sensory neurons. Neuronal
involvement was confirmed when the chili pepper oil
response was abolished by TTX. Submucosal glands from
CF mice trachea that failed to secrete when exposed to chili
pepper oil still responded strongly to EFS. These results
suggested that VIP, neurokinins and other mediators of
local reflexes have the same effector (CFTR), which is
distinct from the central regulation mediated by ACh.
Relevance to airways disease in CF
To our knowledge this is the first report of a defect in gland
responses to local stimulation in CF mouse trachea. It has
implications for CF patients in that local regulation by
‘sensory–efferent’ pathways may be crucial for detecting
noxious stimuli and responding appropriately (De Swert
& Joos, 2006). One such stimulus could be the inhalation
of bacteria such as Pseudomonas aeruginosa. Normal air-
ways are kept sterile by innate immune defences such as
lysozyme, lactoferrin, defensins, bicarbonate and other
antimicrobial factors, which act synergistically to kill
inhaled bacteria or inhibit their growth (Verkman et al.
2003; Song et al. 2005; Salinas et al. 2005; Kreda et al. 2005).
Many of these factors are produced in the submucosal
glands, therefore loss of locally activated gland secretion
described here may contribute to the early impaction of
the glands and reduced delivery of antimicrobial factors to
the airway surface. More research is needed to determine
whether the CFTR-dependent local pathways we elicited
with a capsacinoid stimulus have a role in the early
pathophysiology of airway disease in CF.
The mouse submucosal gland preparation is useful
for studying physiological regulation of human, normal
and CF, airway submucosal glands because of the
nearly perfect qualitative correspondence to human
gland physiology and the great potential for analysis
of the molecular mechanisms afforded by transgenic
and knockout animals. In addition, extensive back-
ground knowledge of mouse airways has been generated
in previous studies directed towards asthma (Tamachi
et al. 2006), neurogenic inflammation (Tripp et al. 2000;
Barnes, 2001; Widdicombe, 2003), bacterial infection
(Chu et al. 2003; Yoon & Hassett, 2004), submucosal gland
morphogenesis (Filali et al. 2002) and various aspects of
airway development, injury and repair. This information
and the genetic tractability of mice should greatly facilitate
further studies of abnormal gland function in CF.
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